Laddar...
Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer
Casein kinase 1δ/ε have been identified as promising therapeutic target for oncology application, including breast and brain cancer. Here, we described our continued efforts in optimization of a lead series of purine scaffold inhibitors that led to identification of two new CK1δ/ε inhibitors 17 and...
Sparad:
| I publikationen: | Bioorg Med Chem |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803353/ https://ncbi.nlm.nih.gov/pubmed/29289448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2017.12.020 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|